Skin Biopsy Market Is Expected to Reach USD 181.6 Million by 2031: Says Allied Market Research

Rise in prevalence of skin cancer, increase in incidences of skin disorders and rise in adoption of minimally invasive procedures drives the growth of the global skin biopsy market. By type, the punch biopsy segment acquired the major share in 2021. By region, Asia-Pacific is anticipated to grow with the fastest CAGR by 2031.


Portland, OR, Feb. 22, 2023 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global skin biopsy market was valued at $101.2 million in 2021, and is projected to reach $181.58 million by 2031, registering a CAGR of 6% from 2022 to 2031. The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and evolving market trends. The market study is a helpful source of information for the frontrunners, new entrants, investors, and shareholders in crafting strategies for the future and heightening their position in the market.       

Download a Free Sample of the Report- https://www.alliedmarketresearch.com/request-sample/13800

Report coverage & details:

Forecast Period2022–2031
Base Year2021
Market Size in 2021$101.20 Million
Market Size in 2031$181.58 Million
CAGR6.0%
No. of Pages in Report245
Segments CoveredType, Indication, End User and Region.
Drivers Rise in prevalence of skin cancer
Increase in incidences of skin disorders
Rise in adoption of minimally invasive procedures
RestraintsHigh cost of skin biopsy procedures
Presence of new alternatives to skin biopsies
OpportunitiesGrowth opportunity in emerging markets

 Impact of Covid-19 on Skin Biopsy Market-

  • The COVID-19 outbreak is had a negative impact on growth of the global skin biopsy market. A drop in the number of skin biopsies was observed starting in March 2020, due to the reductions in non-urgent medical visits which negatively impacted the market during the pandemic.
  • The frequency of skin biopsy procedures also reduced as a result of variables such a reduction in disease early detection, public health regulations, and social isolation. Together with the shortage of transportation services for hospitals and clinics and a reduction in access to general and specialty healthcare, these factors hindered the market's expansion during the pandemic. However, restoration of these services after pandemic is now prioritize, to ensure that patients receive the suitable care and facilities. Also, investment in manufacturing of skin biopsy devices has also increased after the pandemic, which is anticipated to drive the market in coming years.

Procure Complete Report (245 Pages PDF with Insights, Charts, Tables, and Figures)
https://tinyurl.com/mpdxh4ma

The global skin biopsy market is analyzed across type, indication, end user, and region. The study utilizes tabular and graphical representation to offer a thorough study of the segments and their sub-segments. The segmentation can assist investors and market participants to build strategies based on the top revenue-generating and fastest-growing segments identified by the study.

By type, the punch biopsy segment held the largest share in 2021, and garnered more than upto four-fifth of the global skin biopsy market revenue, and is expected to maintain its dominance by 2031 with a highest CAGR during the forecast period.

By indication, the skin cancer segment contributed to more than two-fifth of the global skin biopsy market share in 2021, and is anticipated to grow at a fastest CAGR during the forecast period.

By end user, the hospital and clinics segment accounted for the highest share in 2021, generating around two-fifth of the global skin biopsy market revenue. On the other hand, diagnostic laboratories segment is anticipated to grow at a fastest CAGR during the forecast period.

For Purchase Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/13800

By region, North America held the major share in 2021, and garnered more than two-fifth of the global skin biopsy market revenue. Asia-Pacific, simultaneously, is anticipated to grow at a fastest CAGR from 2022 to 2031.

The key market players analyzed in the global skin biopsy market report include AccuTec, Inc., Becton, Dickinson and Company, Cardinal Health, Innovia Medical (DTR Medical Ltd), Integra LifeSciences, Jai Surgicals Ltd., Kai Group, Paramount Surgimed Ltd., Verna care and World Precision Instruments (WPI). These market players have adopted several strategies including acquisition, branding, expansion and partnership to highlight their expertise in the market. The report is helpful in formulating the business performance and developments by the top players. 

Similar Research Reports for Information, Communication, and Technology:

Telemedicine Market- Global Opportunity Analysis and Industry Forecast, 2021–2030

Macular Edema and Macular Degeneration Market - Global Opportunity Analysis and Industry Forecast, 2021–2030

Newborn Screening Market - Global Opportunity Analysis and Industry Forecast, 2021–2030

Disposable Incontinence Products Market - Global Opportunity Analysis and Industry Forecast, 2021–2030

Hemodialysis and Peritoneal Dialysis Market - Global Opportunity Analysis and Industry Forecast, 2021–2030

                                                                                 
AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model):

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.

Get access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com 

Web: https://www.alliedmarketresearch.com